While many DeFi protocols are still struggling with AMM slippage and MEV attacks, Injective has built a brand new highway for on-chain finance.
As veterans in the crypto space, we have all experienced high slippage, fragmented liquidity, and the headaches of MEV attacks in AMM protocols like Uniswap. Injective brings a fundamental transformation — it does not rely on the constant product model or RFQ model of traditional DEXs, but instead adopts a fully on-chain, MEV-resistant shared order book. This design not only addresses the core pain points of traditional DeFi but also redefines the underlying logic of on-chain trading.
Shared order book: More than just a technical upgrade, it is a paradigm shift
What sets Injective apart is its shared liquidity mechanism—orders from multiple DEXs can be automatically matched across platforms, forming a unified liquidity network. Imagine that various trading platforms are no longer isolated but collectively constitute a massive liquidity pool. This significantly reduces slippage and impermanent loss, providing users with an institutional-level trading experience. Meanwhile, Injective handles transactions with up to 25,000 TPS and nearly zero gas fees, making high-frequency, low-cost on-chain trading a reality.
MultiVM vision: Breaking the boundaries of blockchain
The recently launched native EVM support further amplifies Injective's potential. Now, Ethereum developers can deploy applications on Injective using familiar tools like Solidity, Hardhat, and MetaMask, while enjoying sub-second finality and extremely low costs in the Cosmos ecosystem. This is not just another virtual machine option—it's a complete break of blockchain boundaries. Injective is creating a unified platform that accommodates various technologies, products, and participants.
Bridge between traditional finance and the on-chain world
Injective's ambitions go far beyond crypto-native assets. It is actively driving the RWA (real-world assets) revolution, bringing traditional assets like stocks, gold, and foreign exchange on-chain for the first time. This vision is gaining recognition in the traditional finance sector: Pineapple Financial has set up a $100 million digital asset treasury strategy for INJ, and the first INJ ETF in the U.S. has also submitted an application. These developments indicate that Injective is becoming an important bridge connecting traditional finance and the on-chain world.
The future of financial infrastructure
While most blockchains are still competing for existing crypto market share, Injective has set its sights on a larger goal—redefining the entire financial infrastructure.
From technical architecture to asset types, from user experience to institutional participation, Injective is not patching up the existing DeFi model; rather, it is rethinking from the ground up what on-chain finance should look like.
This is not just an upgrade—it's a revolution, and we are standing at its starting point.
